{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:21:06Z","timestamp":1772191266058,"version":"3.50.1"},"reference-count":33,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1136\/dtb.2020.000061","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T05:25:45Z","timestamp":1624425945000},"page":"103-106","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["What dose of folic acid to use with methotrexate in rheumatoid arthritis?"],"prefix":"10.1136","volume":"59","author":[{"given":"Diane","family":"Bramley","sequence":"first","affiliation":[{"name":"Pharmacy, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"2025082703034860000_59.7.103.1","unstructured":"National Institute for Health and Care Excellence . Rheumatoid arthritis in adults: management (NG100) [online], 2020. Available: www.nice.org.uk\/guidance\/ng100 [Accessed 5 May 2021]."},{"key":"2025082703034860000_59.7.103.2","unstructured":"Scottish Intercollegiate Guidelines Network . Management of early rheumatoid arthritis: a national clinical guideline [online], 2011. Available: https:\/\/www.sign.ac.uk\/media\/1061\/sign123.pdf [Accessed 5 May 2021]."},{"key":"2025082703034860000_59.7.103.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.20516"},{"key":"2025082703034860000_59.7.103.4","doi-asserted-by":"publisher","DOI":"10.1124\/pr.57.2.3"},{"key":"2025082703034860000_59.7.103.5","unstructured":"Methotrexate 2.5mg tablets . Summary of product characteristics. UK: Morningside Healthcare Ltd, 2020."},{"key":"2025082703034860000_59.7.103.6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh088"},{"key":"2025082703034860000_59.7.103.7","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320603"},{"key":"2025082703034860000_59.7.103.8","doi-asserted-by":"crossref","unstructured":"Shea B , Swinden MV , Tanjong Ghogomu E . Folic acid and folinic acid for reducing side-effects in patients receiving methotrexate for rheumatoid arthritis (review). Cochrane Database of Syst Revs 2013;5.","DOI":"10.1002\/14651858.CD000951.pub2"},{"key":"2025082703034860000_59.7.103.9","unstructured":"Pfizer Limited . Maxtrex 2.5 mg tablets. In: Summary of product characteristics. UK: Pfizer Limited, 2020."},{"key":"2025082703034860000_59.7.103.10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew479"},{"key":"2025082703034860000_59.7.103.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330102"},{"key":"2025082703034860000_59.7.103.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.5.423"},{"key":"2025082703034860000_59.7.103.13","first-page":"830","article-title":"Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects","volume":"24","author":"Andersen","year":"1997","journal-title":"J Rheumatol"},{"key":"2025082703034860000_59.7.103.14","first-page":"2374","article-title":"Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement","volume":"31","author":"Hornung","year":"2004","journal-title":"J Rheumatol"},{"key":"2025082703034860000_59.7.103.15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.10.1102"},{"key":"2025082703034860000_59.7.103.16","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7"},{"key":"2025082703034860000_59.7.103.17","first-page":"1727","article-title":"Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis","volume":"31","author":"Kent","year":"2004","journal-title":"J Rheumatol"},{"key":"2025082703034860000_59.7.103.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08876.x"},{"key":"2025082703034860000_59.7.103.19","unstructured":"World Health Organization . Serum and red blood cell folate concentrations for assessing folate statues in populations, 2015. Available: https:\/\/www.who.int\/nutrition\/publications\/micronutrients\/indicators_serum_RBC_folate\/en\/ [Accessed 5 May 2021]."},{"key":"2025082703034860000_59.7.103.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.21295"},{"key":"2025082703034860000_59.7.103.21","first-page":"2110","article-title":"Folic acid alters methotrexate availability in patients with rheumatoid arthritis","volume":"27","author":"Bressolle","year":"2000","journal-title":"J Rheumatol"},{"key":"2025082703034860000_59.7.103.22","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2007.10719635"},{"key":"2025082703034860000_59.7.103.23","doi-asserted-by":"publisher","DOI":"10.1080\/030097401300162888"},{"key":"2025082703034860000_59.7.103.24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-11-199412010-00002"},{"key":"2025082703034860000_59.7.103.25","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0668-4","article-title":"Comparison of two different folic acid doses with methotrexate\u2013a randomized controlled trial (FOLVARI Study)","volume":"17","author":"Dhir","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2025082703034860000_59.7.103.26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4081\/reumatismo.2016.872","article-title":"Real-world experiences of folic acid supplementation (5 versus 30 mg\/week) with methotrexate in rheumatoid arthritis patients: a comparison study","volume":"68","author":"Koh","year":"2016","journal-title":"Reumatismo"},{"key":"2025082703034860000_59.7.103.27","doi-asserted-by":"crossref","first-page":"259.1","DOI":"10.1136\/ejhpharm-2012-000074.457","article-title":"The effect of daily versus weekly folic acid supplementation on the incidence of transaminase elevations in methotrexate-treated patients: CPC108 table 1","volume":"19","author":"Van den Bemt","year":"2012","journal-title":"Eur J Hosp Pharm"},{"key":"2025082703034860000_59.7.103.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2006.01.007"},{"key":"2025082703034860000_59.7.103.29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"2025082703034860000_59.7.103.30","first-page":"1","article-title":"American College of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"2016","author":"Singh","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025082703034860000_59.7.103.31","unstructured":"National Institute for Health and Care Excellence . Clinical knowledge summary DMARDS: scenario: methotrexate, 2020. Available: https:\/\/cks.nice.org.uk\/topics\/dmards\/management\/methotrexate\/ [Accessed 5 May 2021]."},{"key":"2025082703034860000_59.7.103.32","unstructured":"National Rheumatoid Arthritis Society . Methotrexate [online], 2021. Available: https:\/\/www.nras.org.uk\/methotrexate-in-rheumatoid-arthritis [Accessed 5 May 2021]."},{"key":"2025082703034860000_59.7.103.33","unstructured":"Joint Formulary Committee . British National formulary. 81 ed. London: BMJ Group and Pharmaceutical Press, 2021."}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2020.000061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:03:58Z","timestamp":1756289038000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2020.000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,6,23]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/dtb.2020.000061"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2020.000061","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"value":"0012-6543","type":"print"},{"value":"1755-5248","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]}}}